Potential Role of Soluble ST2 Protein in Idiopathic Nephrotic Syndrome Recurrence Following Kidney Transplantation

American Journal of Kidney Diseases

Volumn 54, Issue 3, 2009, Pages 522-532

  Bruneau, Sarah ^a   Le Berre, Ludmilla ^a   Hervé, Caroline ^a   Valanciuté, Asta ^b   Kamal, Maud ^b   Naulet, Jeanne ^a   Tesson, Laurent ^a   Foucher, Yohann ^a   Soulillou, Jean Paul ^a   Sahali, Djillali ^b   Dantal, Jacques ^a  

^a INSERM   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Idiopathic nephrotic syndrome; kidney transplantation; recurrence; sST2

Indexed keywords

MEMBRANE PROTEIN; PROTEIN ST2; TRANSCRIPTION FACTOR C MAF; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; HUMAN; IDIOPATHIC DISEASE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MOUSE; NEPHROTIC SYNDROME; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; PROTEINURIA; RAT; RECURRENT DISEASE;

ADOLESCENT; ADULT; ANIMALS; BIOLOGICAL MARKERS; CELL LINE, TRANSFORMED; CERCOPITHECUS AETHIOPS; CHILD; COS CELLS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MICE; MIDDLE AGED; NEPHROTIC SYNDROME; RATS; RATS, INBRED BUF; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECURRENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 68849097546     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.03.021     Document Type: Article

References (30)

1. Pollak M.R. Focal segmental glomerulosclerosis: Recent advances. Curr Opin Nephrol Hypertens 17 (2008) 138-142
2. Dantal J., Baatard R., Hourmant M., Cantarovich D., Buzelin F., and Soulillou J.P. Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. A one-center study of plasma exchange effects. Transplantation 52 (1991) 827-831
3. Pinto J., Lacerda G., Cameron J.S., Turner D.R., Bewick M., and Ogg C.S. Recurrence of focal segmental glomerulosclerosis in renal allografts. Transplantation 32 (1981) 83-89
4. Savin V.J., Sharma R., Sharma M., et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334 (1996) 878-883
5. Dantal J., Bigot E., Bogers W., et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330 (1994) 7-14
6. Valanciute A., le Gouvello S., Solhonne B., et al. NF-kappa B p65 antagonizes IL-4 induction by c-maf in minimal change nephrotic syndrome. J Immunol 172 (2004) 688-698
7. Lecart S., Lecointe N., Subramaniam A., et al. Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface. Eur J Immunol 32 (2002) 2979-2987
8. Lohning M., Stroehmann A., Coyle A.J., et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci U S A 95 (1998) 6930-6935
9. Coyle A.J., Lloyd C., Tian J., et al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med 190 (1999) 895-902
10. Lambrecht B.N., De Veerman M., Coyle A.J., Gutierrez-Ramos J.C., Thielemans K., and Pauwels R.A. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 106 (2000) 551-559
11. Gajewska B.U., Swirski F.K., Alvarez D., et al. Temporal-spatial analysis of the immune response in a murine model of ovalbumin-induced airways inflammation. Am J Respir Cell Mol Biol 25 (2001) 326-334
12. Cheung W., Wei C.L., Seah C.C., Jordan S.C., and Yap H.K. Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome. Pediatr Nephrol 19 (2004) 627-632
13. Mundel P., Reiser J., Zuniga Mejia Borja A., et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236 (1997) 248-258
14. Hattori M., Akioka Y., Chikamoto H., et al. Increase of integrin-linked kinase activity in cultured podocytes upon stimulation with plasma from patients with recurrent FSGS. Am J Transplant 8 (2008) 1550-1556
15. Le Berre L., Godfrin Y., Gunther E., et al. Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats. J Clin Invest 109 (2002) 491-498
16. Kuroiwa K., Arai T., Okazaki H., Minota S., and Tominaga S. Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem Biophys Res Commun 284 (2001) 1104-1108
17. Coward R.J., Foster R.R., Patton D., et al. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol 16 (2005) 629-637
18. Hoyer J.R., Vernier R.L., Najarian J.S., Raij L., Simmons R.L., and Michael A.F. Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 2 (1972) 343-348
19. Shalhoub R.J. Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 2 (1974) 556-560
20. Xu D., Chan W.L., Leung B.P., et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 187 (1998) 787-794
21. Yanagisawa K., Naito Y., Kuroiwa K., et al. The expression of ST2 gene in helper T cells and the binding of ST2 protein to myeloma-derived RPMI8226 cells. J Biochem (Tokyo) 121 (1997) 95-103
22. Yap H.K., Cheung W., Murugasu B., Sim S.K., Seah C.C., and Jordan S.C. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: Evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 10 (1999) 529-537
23. Grimbert P., Valanciute A., Audard V., et al. Truncation of C-mip (Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization. J Exp Med 198 (2003) 797-807
24. Sahali D., Pawlak A., Valanciute A., et al. A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. J Am Soc Nephrol 13 (2002) 1238-1247
25. Godfrin Y., Dantal J., Perretto S., et al. Study of the in vitro effect on glomerular albumin permselectivity of serum before and after renal transplantation in focal segmental glomerulosclerosis. Transplantation 64 (1997) 1711-1715
26. Dall'Amico R., Ghiggeri G., Carraro M., et al. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 34 (1999) 1048-1055
27. Shimpo M., Morrow D.A., Weinberg E.O., et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 109 (2004) 2186-2190
28. Brunner M., Krenn C., Roth G., et al. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med 30 (2004) 1468-1473
29. Tajima S., Oshikawa K., Tominaga S., and Sugiyama Y. The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest 124 (2003) 1206-1214
30. Oshikawa K., Kuroiwa K., Tago K., et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 164 (2001) 277-281